![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Real-World Effectiveness of Cabotegravir +
Rilpivirine vs Standard of Care Oral Regimens in the US in OPERA Cohort
|
|
|
CROI 2024 March 3-6 Denver
Ricky K. Hsu, Michael Sension, Jennifer S. Fusco, Laurence Brunet, Quateka Cochran, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Michael B. Wohlfeiler, Brooke Levis, Gregory P. Fusco
![0320241](../images/032024/032024-2/0320241.gif)
![0320242](../images/032024/032024-2/0320242.gif)
![0320243](../images/032024/032024-2/0320243.gif)
![0320244](../images/032024/032024-2/0320244.gif)
![0320245](../images/032024/032024-2/0320245.gif)
![0320246](../images/032024/032024-2/0320246.gif)
![0320247](../images/032024/032024-2/0320247.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|